InvestorsHub Logo
Followers 314
Posts 24877
Boards Moderated 9
Alias Born 10/26/2008

Re: None

Tuesday, 09/07/2021 8:55:54 AM

Tuesday, September 07, 2021 8:55:54 AM

Post# of 1580
The presentation will provide an update on the three ongoing PDS0101 Phase 2 clinical trials. The talk will also provide updates on progression of two other investigational pipeline products PDS0102 (Versamune®-TARP) and PDS0103 (Versamune®-MUC1) into human clinical trials. The conference is taking place virtually from September 13 - 15, 2021.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PDSB News